Indigenous stroke patients treated worse: National audit 9 Feb 2012 0 comments A new audit of Australian hospitals shows Indigenous stroke patients receive an inferior level of care within the same hospitals, having a 30% lower chance of receiving treatment from a stroke unit…
Placebo adherence saves lives? 2 Feb 2012 0 comments Trial participants who conscientiously take their placebos die less than those who have worse adherence to placebos – and the association resists being explained away by confounding.
Space flight doesn’t lower testosterone levels 10 Nov 2011 0 comments Aspiring astronauts and their endocrinologists can rest assured that trips in zero gravity will not result in decreased testosterone levels.
Unfriending pharma? 13 Oct 2011 0 comments Doctors and medical students using social networking websites face a conflict of interest if they accept connection requests from pharmaceutical companies.
Guidance needed for holiest Jewish day 6 Oct 2011 0 comments The holiest day in the Jewish calendar, Yom Kippur, is approaching this weekend, with experts highlighting the unique risks it raises for patients with type 1 diabetes.
Warning over use of epilepsy drug for weight loss 6 Oct 2011 0 comments The TGA has issued a warning about the dangers of prescribing topiramate for weight loss, saying it can cause serious side effects in patients.
Gene patenting given the go-ahead 29 Sep 2011 0 comments A senate committee has recommended the Federal Government not pass a bill seeking to stop patents of genes and biological materials.
GLP-1 agonists may worsen retinopathy: pilot study 22 Sep 2011 0 comments Retinopathy may be made worse by improvements in glycaemic control through the use of GLP-1 agonists, a pilot study finds.
Icodextrin interference still a problem 22 Sep 2011 0 comments Newer blood glucose monitors still overestimate blood glucose when they are present, a study finds.
Incretin-based therapy and pancreatic cancer 22 Sep 2011 0 comments Australia should ''urgently'' link cancer and diabetes prescription databases to investigate suggested links between incretin-based therapies and cancer.